Long-Term Liabilities: The sum of all non-current liabilities.
Heron Therapeutics, Inc. (HRTX) had Long-Term Liabilities of $145.45M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$40.59M |
|
$-2.95M |
|
$11.12M |
|
$29.47M |
|
$40.55M |
|
$0.04M |
|
$-2.99M |
|
$-2.95M |
|
$-2.95M |
|
$-2.95M |
|
$-2.95M |
|
$-2.95M |
|
$-2.95M |
|
$0.04M |
|
$0.69M |
|
166.71M |
|
166.71M |
|
$-0.02 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$238.07M |
|
$12.40M |
|
$17.81M |
|
$255.88M |
|
$96.10M |
|
$140.64M |
|
|
Long-Term Liabilities |
$145.45M |
$241.54M |
|
$13.28M |
|
$14.33M |
|
$14.33M |
|
188.31M |
|
| Cash Flow Statement Financials | |
$-27.59M |
|
$16.01M |
|
$14.43M |
|
$25.80M |
|
$28.65M |
|
$2.85M |
|
$10.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.48 |
|
-- |
|
-- |
|
0.91 |
|
9.81 |
|
72.61% |
|
0.09% |
|
0.09% |
|
-- |
|
-7.28% |
|
-7.28% |
|
$-27.81M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.12 |
|
0.45 |
|
198.65 |
|
-22.24% |
|
-20.61% |
|
-1.15% |
|
-1.91% |
|
$0.08 |
|
$-0.17 |
|
$-0.17 |
|